Parallels between the human heart and a toilet? Believe it. In a study sponsored by biotechnology company Esperion Therapeutics Inc. of Ann Arbor, Mich., researchers have discovered a sort of “liquid ...
A synthetic version of “good” cholesterol, injected into arteries, cleared them of plaque like “liquid Drano” and reduced artery disease in just six weeks, says a breakthrough new study that could ...
CHICAGO (AP) _ Intravenous doses of a synthetic component of ``good'' cholesterol reduced artery disease in just six weeks in a small study with startlingly big implications for treating the nation's ...
Intravenous doses of a synthetic component of “good” cholesterol reduced artery disease in just six weeks in a small study with startlingly big implications for treating the nation’s No. 1 killer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results